These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

931 related items for PubMed ID: 19616998

  • 1. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J, Pardi D, Hornfeldt CS, Inhaber N.
    Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
    Xyrem International Study Group.
    J Clin Sleep Med; 2005 Oct 15; 1(4):391-7. PubMed ID: 17564408
    [Abstract] [Full Text] [Related]

  • 3. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J, Houghton WC.
    Sleep; 2006 Jul 15; 29(7):939-46. PubMed ID: 16895262
    [Abstract] [Full Text] [Related]

  • 4. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
    Huang YS, Guilleminault C.
    Pediatr Neurol; 2009 Jul 15; 41(1):9-16. PubMed ID: 19520267
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
    Sleep; 2002 Feb 01; 25(1):42-9. PubMed ID: 11833860
    [Abstract] [Full Text] [Related]

  • 6. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
    Prescrire Int; 2007 Jun 01; 16(89):98-101. PubMed ID: 17582923
    [Abstract] [Full Text] [Related]

  • 7. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study.
    Ondo WG, Perkins T, Swick T, Hull KL, Jimenez JE, Garris TS, Pardi D.
    Arch Neurol; 2008 Oct 01; 65(10):1337-40. PubMed ID: 18852348
    [Abstract] [Full Text] [Related]

  • 8. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy.
    Mamelak M, Black J, Montplaisir J, Ristanovic R.
    Sleep; 2004 Nov 01; 27(7):1327-34. PubMed ID: 15586785
    [Abstract] [Full Text] [Related]

  • 9. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
    Mansukhani MP, Kotagal S.
    Sleep Med; 2012 Jun 01; 13(6):606-10. PubMed ID: 22445591
    [Abstract] [Full Text] [Related]

  • 10. Rapid occurrence of depression following addition of sodium oxybate to modafinil.
    Rossetti AO, Heinzer RC, Tafti M, Buclin T.
    Sleep Med; 2010 May 01; 11(5):500-1. PubMed ID: 20133191
    [No Abstract] [Full Text] [Related]

  • 11. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
    Black J, Pardi D, Hornfeldt CS, Inhaber N.
    J Clin Sleep Med; 2010 Dec 15; 6(6):596-602. PubMed ID: 21206549
    [Abstract] [Full Text] [Related]

  • 12. A safety trial of sodium oxybate in patients with obstructive sleep apnea: Acute effects on sleep-disordered breathing.
    George CF, Feldman N, Inhaber N, Steininger TL, Grzeschik SM, Lai C, Zheng Y.
    Sleep Med; 2010 Jan 15; 11(1):38-42. PubMed ID: 19897413
    [Abstract] [Full Text] [Related]

  • 13. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group.
    Ann Neurol; 1998 Jan 15; 43(1):88-97. PubMed ID: 9450772
    [Abstract] [Full Text] [Related]

  • 14. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
    Bittencourt LR, Lucchesi LM, Rueda AD, Garbuio SA, Palombini LO, Guilleminault C, Tufik S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):552-9. PubMed ID: 18053628
    [Abstract] [Full Text] [Related]

  • 15. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia.
    Scharf MB, Baumann M, Berkowitz DV.
    J Rheumatol; 2003 May 15; 30(5):1070-4. PubMed ID: 12734908
    [Abstract] [Full Text] [Related]

  • 16. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
    Högl B, Saletu M, Brandauer E, Glatzl S, Frauscher B, Seppi K, Ulmer H, Wenning G, Poewe W.
    Sleep; 2002 Dec 15; 25(8):905-9. PubMed ID: 12489899
    [Abstract] [Full Text] [Related]

  • 17. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J, Swick T, Bogan R, Lai C, Carter LP.
    Sleep Med; 2016 Aug 15; 24():57-62. PubMed ID: 27810187
    [Abstract] [Full Text] [Related]

  • 18. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
    Poza-Aldea JJ.
    Rev Neurol; 2016 Aug 15; 48(1):27-31. PubMed ID: 19145563
    [Abstract] [Full Text] [Related]

  • 19. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
    Harsh JR, Hayduk R, Rosenberg R, Wesnes KA, Walsh JK, Arora S, Niebler GE, Roth T.
    Curr Med Res Opin; 2006 Apr 15; 22(4):761-74. PubMed ID: 16684437
    [Abstract] [Full Text] [Related]

  • 20. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
    Xyrem International Study Group.
    Sleep Med; 2005 Sep 15; 6(5):415-21. PubMed ID: 16099718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.